Clinical Scorecard: Cutaneous SCC Trends Across Sex and Age
At a Glance
Category
Detail
Condition
Key Mechanisms
Increased incidence rates of carcinoma in situ and cSCC over time, with specific annual percentage changes.
Target Population
Care Setting
Key Highlights
cSCC incidence rates reached 131.6 per 100,000 person-years in males and 77.7 in females by 2023, with annual percentage increases of 2.6% and 3.1%, respectively.
Carcinoma in situ incidence increased significantly, with annual percentage changes of 6.4% in males and 5.8% in females, reaching 89.4 and 78.6 per 100,000 person-years by 2023.
KA incidence declined over the study period, reaching approximately 28 per 100,000 person-years.
Guideline-Based Recommendations
Diagnosis
Management
Consideration of increasing incidence trends in clinical management and surveillance, including tailored follow-up strategies.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients aged 20 years or older with first-time diagnoses of cSCC, carcinoma in situ, or KA.
Increased awareness and management strategies may be needed due to rising incidence rates.
Clinical Best Practices
Acknowledge limitations in diagnostic practices and potential confounding factors, and recommend strategies to mitigate these issues.
